Promazina
Brand names,
Promazina
Analogs
Promazina
Brand Names Mixture
Promazina
Chemical_Formula
C17H20N2S
Promazina
RX_link
No information avaliable
Promazina
fda sheet
Promazina
msds (material safety sheet)
Promazina
Synthesis Reference
No information avaliable
Promazina
Molecular Weight
284.42 g/mol
Promazina
Melting Point
< 25 oC
Promazina
H2O Solubility
14.2 mg/L
Promazina
State
Liquid
Promazina
LogP
4.893
Promazina
Dosage Forms
Tablet; Oral liquid; Injection
Promazina
Indication
Used as an adjunct for short term treatment of moderate and severe psychomotor agitation. Also used to treat agitation or restlessness in the elderly.
Promazina
Pharmacology
Promazine belongs to a group of medications known as the phenothiazine antipsychotics. It acts by blocking a variety of receptors in the brain, particularly dopamine receptors. Dopamine is involved in transmitting signals between brain cells. When there is an excess amount of dopamine in the brain it causes over-stimulation of dopamine receptors. These receptors normally act to modify behaviour and over-stimulation may result in psychotic illness. Promazine hydrochloride blocks these receptors and stops them becoming over-stimulated, thereby helping to control psychotic illness. Promazine has weak extrapyramidal and autonomic side effects which lead to its use in the elderly, for restless or psychotic patients. Its anti-psychotic effect is also weaker and it is not useful in general psychiatry.
Promazina
Absorption
Absorption may be erratic and peak plasma concentrations show large interindividual differences.
Promazina
side effects and Toxicity
Side effects include: extrapyramidal symptoms, drowsiness, weight gain, dry mouth, constipation, endocrine effects (such as gynaecomastia and menstrual disturbance), sensitivity to sunlight and haemolytic anaemia.
Promazina
Patient Information
No information avaliable
Promazina
Organisms Affected
Humans and other mammals